載入...
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects
Sorafenib (Sor) is a multi-kinase inhibitor. It is recommended for the treatment of advanced hepatocellular carcinoma (HCC). However, Sor has severe and marked side effects. On the other hand, taurine (Tau) has been shown to enhance the therapeutic effects of cancer chemotherapy and also to enhance...
Na minha lista:
| 發表在: | Asian Pac J Cancer Prev |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
West Asia Organization for Cancer Prevention
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982677/ https://ncbi.nlm.nih.gov/pubmed/31653148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.10.3007 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|